Advertisement
Screener

ASTROTECH Corp (ASTC) Selling, General and Administrative Expense

2.8 / 5 stars · 68/120 Roast Me

ASTROTECH Corp Selling, General and Administrative Expense

ASTROTECH Corp (ASTC) reported Selling, General and Administrative Expense of $2.08 million for the 3-month period ending 2026-03-31, per its 10-Q/A filed 2026-08-06.

Financial Statements › Expense Statement › Operating Expenses

us-gaap:SellingGeneralAndAdministrativeExpense · last filed 2026-08-06

  • ASTROTECH Corp selling, general and administrative expense for the quarter ending 2026-03-31 was $2.08M, a 1.42% decline year-over-year.
  • ASTROTECH Corp selling, general and administrative expense for the quarter ending 2025-12-31 was $2.08M, a 1.86% increase year-over-year.
  • ASTROTECH Corp selling, general and administrative expense for the quarter ending 2025-09-30 was $1.78M, a 5.45% increase year-over-year.
  • ASTROTECH Corp selling, general and administrative expense for the quarter ending 2025-06-30 was $1.23M, a 29.60% decline year-over-year.
  • ASTROTECH Corp selling, general and administrative expense for fiscal 2025 was $7.07M, a 2.40% decline from fiscal 2024.
  • ASTROTECH Corp selling, general and administrative expense for fiscal 2024 was $7.24M, a 25.39% increase from fiscal 2023.
  • ASTROTECH Corp selling, general and administrative expense for fiscal 2023 was $5.78M, a 3.85% decline from fiscal 2022.
  • ASTROTECH Corp selling, general and administrative expense for fiscal 2022 was $6.01M, a 26.68% increase from fiscal 2021.
Period endSelling, General and Administrative Expense 3 monthSelling, General and Administrative Expense 3 month as first filedSelling, General and Administrative Expense 6 monthSelling, General and Administrative Expense 6 month as first filedSelling, General and Administrative Expense 9 monthSelling, General and Administrative Expense 9 month as first filedSelling, General and Administrative Expense 12 monthSelling, General and Administrative Expense 12 month as first filed
2026-03-31$2.08M
10-Q/A · filed 2026-08-06
$4.16M
derived: sum of 2 quarters · filed 2026-08-06
$5.94M
10-Q/A · filed 2026-08-06
$7.17M
derived: sum of 4 quarters · filed 2026-08-06
2025-12-31$2.08M
10-Q · filed 2026-02-13
$3.86M
10-Q · filed 2026-02-13
$5.08M
derived: sum of 3 quarters · filed 2026-02-13
$7.20M
derived: sum of 4 quarters · filed 2026-08-06
2025-09-30$1.78M
10-Q · filed 2025-11-13
$3.00M
derived: sum of 2 quarters · filed 2025-11-13
$5.12M
derived: sum of 3 quarters · filed 2026-08-06
$7.16M
derived: sum of 4 quarters · filed 2026-08-06
2025-06-30$1.23M
derived: 10-K 12 month − 10-Q/A 9 month · filed 2025-09-26
$3.34M
derived: sum of 2 quarters · filed 2026-08-06
$5.38M
derived: sum of 3 quarters · filed 2026-08-06
$7.07M
10-K · filed 2025-09-26
2025-03-31$2.12M
10-Q/A · filed 2026-08-06
$4.15M
derived: sum of 2 quarters · filed 2026-08-06
$5.84M
10-Q/A · filed 2026-08-06
$7.58M
derived: sum of 4 quarters · filed 2026-08-06
2024-12-31$2.04M
10-Q · filed 2026-02-13
$3.73M
10-Q · filed 2026-02-13
$5.47M
derived: sum of 3 quarters · filed 2026-02-13
$7.30M
derived: sum of 4 quarters · filed 2026-02-13
2024-09-30$1.69M
10-Q · filed 2025-11-13
$3.43M
derived: sum of 2 quarters · filed 2025-11-13
$5.26M
derived: sum of 3 quarters · filed 2025-11-13
$7.28M
derived: sum of 4 quarters · filed 2025-11-13
2024-06-30$1.74M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-09-26
$3.57M
derived: sum of 2 quarters · filed 2025-09-26
$5.59M
derived: sum of 3 quarters · filed 2025-09-26
$7.24M
10-K · filed 2025-09-26
2024-03-31$1.83M
10-Q · filed 2025-05-14
$3.85M
derived: sum of 2 quarters · filed 2025-05-14
$5.50M
10-Q · filed 2025-05-14
$6.67M
derived: sum of 4 quarters · filed 2025-05-14
2023-12-31$2.02M
10-Q · filed 2025-02-14
$3.67M
10-Q · filed 2025-02-14
$4.84M
derived: sum of 3 quarters · filed 2025-02-14
$6.24M
derived: sum of 4 quarters · filed 2025-02-14
2023-09-30$1.65M
10-Q · filed 2024-11-13
$2.81M
derived: sum of 2 quarters · filed 2024-11-13
$4.22M
derived: sum of 3 quarters · filed 2024-11-13
$5.78M
derived: sum of 4 quarters · filed 2024-11-13
2023-06-30$1.17M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-09-20
$2.58M
derived: sum of 2 quarters · filed 2024-09-20
$4.13M
derived: sum of 3 quarters · filed 2024-09-20
$5.78M
10-K · filed 2024-09-20
2023-03-31$1.41M
10-Q · filed 2024-05-14
$2.96M
derived: sum of 2 quarters · filed 2024-05-14
$4.61M
10-Q · filed 2024-05-14
$5.98M
derived: sum of 4 quarters · filed 2024-05-14
2022-12-31$1.56M
10-Q · filed 2024-02-13
$3.20M
10-Q · filed 2024-02-13
$4.58M
derived: sum of 3 quarters · filed 2024-02-13
$6.05M
derived: sum of 4 quarters · filed 2024-02-13
2022-09-30$1.64M
10-Q · filed 2023-11-13
$3.02M
derived: sum of 2 quarters · filed 2023-11-13
$4.49M
derived: sum of 3 quarters · filed 2023-11-13
$6.22M
derived: sum of 4 quarters · filed 2023-11-13
2022-06-30$1.38M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-09-28
$2.85M
derived: sum of 2 quarters · filed 2023-09-28
$4.58M
derived: sum of 3 quarters · filed 2023-09-28
$6.01M
10-K · filed 2023-09-28
2022-03-31$1.48M
10-Q · filed 2023-05-12
$3.20M
derived: sum of 2 quarters · filed 2023-05-12
$4.63M
10-Q · filed 2023-05-12
$5.96M
derived: sum of 4 quarters · filed 2023-05-12
2021-12-31$1.73M
10-Q · filed 2023-02-13
$3.15M
10-Q · filed 2023-02-13
$4.49M
derived: sum of 3 quarters · filed 2023-02-13
$6.17M
derived: sum of 4 quarters · filed 2023-02-13
2021-09-30$1.43M
10-Q · filed 2022-11-14
$2.76M
derived: sum of 2 quarters · filed 2022-11-14
$4.44M
derived: sum of 3 quarters · filed 2022-11-14
$5.24M
derived: sum of 4 quarters · filed 2022-11-14
2021-06-30$1.33M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-09-15
$3.01M
derived: sum of 2 quarters · filed 2022-09-15
$3.81M
derived: sum of 3 quarters · filed 2022-09-15
$4.74M
10-K · filed 2022-09-15
2021-03-31$1.68M
10-Q · filed 2022-05-13
$2.48M
derived: sum of 2 quarters · filed 2022-05-13
$3.41M
10-Q · filed 2022-05-13
$4.62M
derived: sum of 4 quarters · filed 2022-05-13
2020-12-31$803.00K
10-Q · filed 2022-02-14
$1.73M
10-Q · filed 2022-02-14
$2.94M
derived: sum of 3 quarters · filed 2022-02-14
$4.13M
derived: sum of 4 quarters · filed 2022-02-14
2020-09-30$926.00K
10-Q · filed 2021-11-12
$2.14M
derived: sum of 2 quarters · filed 2021-11-12
$3.33M
derived: sum of 3 quarters · filed 2021-11-12
$4.44M
derived: sum of 4 quarters · filed 2021-11-12
2020-06-30$1.21M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-09-21
$2.40M
derived: sum of 2 quarters · filed 2021-09-21
$3.51M
derived: sum of 3 quarters · filed 2021-09-21
$4.72M
10-K · filed 2021-09-21
2020-03-31$1.19M
10-Q · filed 2021-05-14
$2.30M
derived: sum of 2 quarters · filed 2021-05-14
$3.50M
10-Q · filed 2021-05-14
$4.71M
derived: sum of 4 quarters · filed 2021-05-14
2019-12-31$1.11M
10-Q · filed 2021-02-16
$2.31M
10-Q · filed 2021-02-16
$3.52M
derived: sum of 3 quarters · filed 2021-02-16
$4.76M
derived: sum of 4 quarters · filed 2021-02-16
2019-09-30$1.20M
10-Q · filed 2020-11-13
$2.41M
derived: sum of 2 quarters · filed 2020-11-13
$3.65M
derived: sum of 3 quarters · filed 2020-11-13
$4.93M
derived: sum of 4 quarters · filed 2020-11-13
2019-06-30$1.21M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-09-08
$2.45M
derived: sum of 2 quarters · filed 2020-09-08
$3.73M
derived: sum of 3 quarters · filed 2020-09-08
$4.88M
10-K · filed 2020-09-08
2019-03-31$1.24M
10-Q · filed 2020-05-14
$2.52M
derived: sum of 2 quarters · filed 2020-05-14
$3.67M
10-Q · filed 2020-05-14
$4.90M
derived: sum of 4 quarters · filed 2020-05-14
2018-12-31$1.29M
10-Q · filed 2020-02-14
$2.43M
10-Q · filed 2020-02-14
$3.66M
derived: sum of 3 quarters · filed 2020-02-14
$5.03M
derived: sum of 4 quarters · filed 2020-02-14
2018-09-30$1.14M
10-Q · filed 2019-11-14
$2.38M
derived: sum of 2 quarters · filed 2019-11-14
$3.74M
derived: sum of 3 quarters · filed 2019-11-14
$5.34M
derived: sum of 4 quarters · filed 2019-11-14
2018-06-30$1.23M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-09-30
$2.60M
derived: sum of 2 quarters · filed 2019-09-30
$4.20M
derived: sum of 3 quarters · filed 2019-09-30
$5.63M
10-K · filed 2019-09-30
2018-03-31$1.36M
10-Q · filed 2019-05-13
$2.96M
derived: sum of 2 quarters · filed 2019-05-13
$4.40M
10-Q · filed 2019-05-13
$6.06M
derived: sum of 4 quarters · filed 2019-05-13
2017-12-31$1.60M
10-Q · filed 2019-02-12
$3.03M
10-Q · filed 2019-02-12
$4.70M
derived: sum of 3 quarters · filed 2019-02-12
$6.33M
derived: sum of 4 quarters · filed 2019-02-12
2017-09-30$1.41M
10-Q · filed 2018-11-14
$3.10M
derived: sum of 2 quarters · filed 2018-11-14
$4.73M
derived: sum of 3 quarters · filed 2018-11-14
$6.37M
derived: sum of 4 quarters · filed 2018-11-14
2017-06-30$1.69M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-09-25
$3.32M
derived: sum of 2 quarters · filed 2018-09-25
$4.96M
derived: sum of 3 quarters · filed 2018-09-25
$7.51M
10-K · filed 2018-09-25
2017-03-31$1.63M
10-Q · filed 2018-05-15
$3.27M
derived: sum of 2 quarters · filed 2018-05-15
$5.82M
10-Q · filed 2018-05-15
$7.69M
derived: sum of 4 quarters · filed 2018-05-15
2016-12-31$1.64M
10-Q · filed 2018-02-12
$4.18M
10-Q · filed 2018-02-12
$6.06M
derived: sum of 3 quarters · filed 2018-02-12
$7.93M
derived: sum of 4 quarters · filed 2018-02-12
2016-09-30$2.55M
10-Q/A · filed 2018-02-12
$4.42M
derived: sum of 2 quarters · filed 2018-02-12
$6.30M
derived: sum of 3 quarters · filed 2018-02-12
$7.97M
derived: sum of 4 quarters · filed 2018-02-12
2016-06-30$1.88M
derived: 10-K 12 month − 10-Q 9 month · filed 2017-09-18
$3.75M
derived: sum of 2 quarters · filed 2017-09-18
$5.42M
derived: sum of 3 quarters · filed 2017-09-18
$7.71M
10-K · filed 2017-09-18
2016-03-31$1.88M
10-Q · filed 2017-05-09
$3.55M
derived: sum of 2 quarters · filed 2017-05-09
$5.83M
10-Q · filed 2017-05-09
$13.14M
derived: sum of 4 quarters · filed 2017-05-09
2015-12-31$1.67M
10-Q · filed 2017-02-13
$3.96M
10-Q · filed 2017-02-13
$11.27M
derived: sum of 3 quarters · filed 2017-02-13
$12.95M
derived: sum of 4 quarters · filed 2017-02-13
2015-09-30$2.29M
10-Q · filed 2016-11-14
$9.60M
derived: sum of 2 quarters · filed 2016-11-14
$11.28M
derived: sum of 3 quarters · filed 2016-11-14
$13.29M
derived: sum of 4 quarters · filed 2016-11-14
2015-06-30$7.31M
derived: 10-K 12 month − 10-Q 9 month · filed 2016-09-29
$8.99M
derived: sum of 2 quarters · filed 2016-09-29
$11.01M
derived: sum of 3 quarters · filed 2016-09-29
$12.97M
10-K · filed 2016-09-29
2015-03-31$1.68M
10-Q · filed 2016-05-11
$3.69M
derived: sum of 2 quarters · filed 2016-05-11
$5.65M
10-Q · filed 2016-05-11
$8.76M
derived: sum of 4 quarters · filed 2016-05-11
2014-12-31$2.01M
10-Q · filed 2016-02-10
$3.97M
10-Q · filed 2016-02-10
$7.07M
derived: sum of 3 quarters · filed 2016-02-10
$8.51M
derived: sum of 4 quarters · filed 2016-02-10
2014-09-30$1.96M
10-Q · filed 2015-11-12
$5.06M
derived: sum of 2 quarters · filed 2015-11-12
$6.49M
derived: sum of 3 quarters · filed 2015-11-12
$8.52M
derived: sum of 4 quarters · filed 2015-11-12
2014-06-30$3.10M
derived: 10-K 12 month − 10-Q 9 month · filed 2015-09-22
$4.53M
derived: sum of 2 quarters · filed 2015-09-22
$6.56M
derived: sum of 3 quarters · filed 2015-09-22
$8.11M
10-K · filed 2015-09-22
$8.89M
10-K · filed 2014-09-30
2014-03-31$1.43M
10-Q · filed 2015-05-11
$1.59M
10-Q · filed 2014-05-14
$3.46M
derived: sum of 2 quarters · filed 2015-05-11
$5.01M
10-Q · filed 2015-05-11
$5.54M
10-Q · filed 2014-05-14
$6.46M
derived: sum of 4 quarters · filed 2015-05-11
2013-12-31$2.02M
10-Q · filed 2015-02-17
$2.21M
10-Q · filed 2014-02-14
$3.58M
10-Q · filed 2015-02-17
$3.95M
10-Q · filed 2014-02-14
$5.02M
derived: sum of 3 quarters · filed 2015-02-17
$6.78M
derived: sum of 4 quarters · filed 2015-02-17
2013-09-30$1.55M
10-Q · filed 2014-11-14
$1.74M
10-Q · filed 2013-11-14
$3.00M
derived: sum of 2 quarters · filed 2014-11-14
$4.76M
derived: sum of 3 quarters · filed 2014-11-14
$6.24M
derived: sum of 4 quarters · filed 2014-11-14
2013-06-30$1.45M
derived: 10-K 12 month − 10-Q 9 month · filed 2014-09-30
$3.21M
derived: sum of 2 quarters · filed 2014-09-30
$4.69M
derived: sum of 3 quarters · filed 2014-09-30
$6.79M
10-K · filed 2014-09-30
2013-03-31$1.76M
10-Q · filed 2014-05-14
$3.24M
derived: sum of 2 quarters · filed 2014-05-14
$5.34M
10-Q · filed 2014-05-14
$6.96M
derived: sum of 4 quarters · filed 2014-05-14
2012-12-31$1.48M
10-Q · filed 2014-02-14
$3.58M
10-Q · filed 2014-02-14
$5.20M
derived: sum of 3 quarters · filed 2014-02-14
$7.01M
derived: sum of 4 quarters · filed 2014-02-14
2012-09-30$2.10M
10-Q · filed 2013-11-14
$3.71M
derived: sum of 2 quarters · filed 2013-11-14
$5.53M
derived: sum of 3 quarters · filed 2013-11-14
$7.24M
derived: sum of 4 quarters · filed 2013-11-14
2012-06-30$1.62M
derived: 10-K 12 month − 10-Q 9 month · filed 2013-10-15
$3.43M
derived: sum of 2 quarters · filed 2013-10-15
$5.14M
derived: sum of 3 quarters · filed 2013-10-15
$7.07M
10-K · filed 2013-10-15
2012-03-31$1.81M
10-Q · filed 2013-05-15
$3.52M
derived: sum of 2 quarters · filed 2013-05-15
$5.45M
10-Q · filed 2013-05-15
$7.49M
derived: sum of 4 quarters · filed 2013-05-15
2011-12-31$1.71M
10-Q · filed 2013-02-14
$3.64M
10-Q · filed 2013-02-14
$5.67M
derived: sum of 3 quarters · filed 2013-02-14
$7.61M
derived: sum of 4 quarters · filed 2013-02-14
2011-09-30$1.93M
10-Q · filed 2012-11-14
$3.96M
derived: sum of 2 quarters · filed 2012-11-14
$5.91M
derived: sum of 3 quarters · filed 2012-11-14
$8.02M
derived: sum of 4 quarters · filed 2012-11-14
2011-06-30$2.04M
derived: 10-K 12 month − 10-Q 9 month · filed 2012-09-28
$3.98M
derived: sum of 2 quarters · filed 2012-09-28
$6.09M
derived: sum of 3 quarters · filed 2012-09-28
$8.40M
10-K · filed 2012-09-28
2011-03-31$1.94M
10-Q · filed 2012-05-07
$4.06M
derived: sum of 2 quarters · filed 2012-05-07
$6.37M
10-Q · filed 2012-05-07
2010-12-31$2.12M
10-Q · filed 2012-02-03
$4.43M
10-Q · filed 2012-02-03
2010-09-30$2.31M
10-Q · filed 2011-11-14

Similar stocks

Stock NameCountryMarket CapPE Ratio
Bionano Genomics, Inc. (BNGO)United States$0.020B-0.42
HARVARD BIOSCIENCE INC (HBIO)United States$0.037B-2.70
Precipio, Inc. (PRPO)United States$0.043B-36.70
Seer, Inc. (SEER)United States$0.104B-1.34
Nautilus Biotechnology, Inc. (NAUT)United States$0.129B-4.16
Quanterix Corp (QTRX)United States$0.150B-1.65
EyePoint, Inc. (EYPT)United States$0.314B-3.96
908 Devices Inc. (MASS)United States$0.476B-9.53
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB)United States$0.491B-3.95
Cytek Biosciences, Inc. (CTKB)United States$0.744B-7.15